Formerly The COVID Advisor — evidence-based analysis of Long COVID, immune injury, and post-viral disease
Hyperbaric Oxygen Therapy for Long COVID and Post COVID Vaccine Symptoms
Get link
Facebook
X
Pinterest
Email
Other Apps
By
Editorial Team
-
“When I first heard about it [HBOT] I thought, ‘this is goofy,’” said Dr. Paul Marik. Then he encountered a competitive cyclist patient who became bedridden after COVID vaccinations. “He was completely incapacitated. He went for hyperbaric oxygen [and] within about five or six sessions [he] was back on his bicycle.”
Marik, co-founder of the Front Line COVID-19 Critical Care Alliance (FLCCC), told The Epoch Times, that some patients who have spike protein injuries have responded particularly well to hyperbaric oxygen.
Dr. Paul Marik, co-founder of the Front Line COVID-19 Critical Care Alliance (FLCCC) and former Chief of the Division of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School, at the FLCCC conference “Understanding & Treating Spike Protein-Induced Diseases” in Kissimmee, Fla. on Oct. 14, 2022. (The Epoch Times)
How Does HBOT Work?
Hyperbaric oxygen therapy (HBOT) involves patients breathing in 100 percent pure oxygen in a chamber at an atmospheric pressure higher than normal sea level (1 standard atmosphere, or ATM).
Since oxygen normally only makes up around 21 percent of air, the increased pressure of pure oxygen would further increase oxygen levels in the blood.
Depending on the pressure administered, blood oxygen levels can be increased to three times the normal level.
The treatment is mostly used for wound healing, including both internal and external wounds.
Cells need oxygen to function. The mitochondria uses oxygen to break down sugars into energy, so increased blood oxygen levels drive tissue growth and regeneration. Increased oxygen levels also clear bacterial infections.
HBOT is currently approved as a treatment for 15 different wounds and health conditions including carbon monoxide poisoning, tissue damage, blood loss, burns, skin grafts, soft tissue infections, and intracranial abscesses.
Outside of the United States, Russia lists 70 diseases that can be treated by HBOT, China lists 49, and Japan lists 33.
Dr. Paul Harch, a renowned HBOT expert and founder of Harch Hyperbarics, said at the FLCCC conference in Kissimmee, Florida that a major underlying pathology of wounding is inflammation; HBOT repairs wounding by reducing inflammation and promoting regrowth.
Since inflammation is an underlying pathology for many diseases, this makes HBOT conceptually applicable for various conditions, even wounding from diabetes, which is a metabolic disease driven by inflammation.
Epigenetics are factors that change gene activity. Depending on environmental factors including stress, diet, drugs, and treatments, certain genes can be activated or suppressed.
“Surprisingly, it is the increased pressure, rather than the increase in the concentration of dissolved oxygen, that appears to mediate these effects,” the FLCCC doctors wrote in their treatment recommendations.
For HBOT, the higher the oxygen pressure, the greater the change in gene expression, and the higher the general benefit.
Therefore the FLCCC recommends to use HBOT at a high atmospheric pressure. But treatment regimens need to be monitored by a clinician to prevent oxygen toxicity.
An in vitro study on human microvascular cells found that cells exposed to a HBOT treatment at 2.4 standard atmospheres (ATM) for 60 minutes, had changes in gene expression in 8,101 genes 24 hours later.
HBOT increased the expression of anti-inflammatory genes and reduced the activity of pro-inflammatory genes.
Since cells exposed to pure oxygen at normal atmospheric pressure had “minimal change” in their gene expression, this demonstrated that pressure is the key player in the overall therapy.
Another study on rats further indicated the importance of pressure. The study showed that depending on the pressure of the environment, different numbers of genes were expressed.
The authors of the study exposed rats to normal air and pure oxygen at normal atmospheric pressure and higher pressures. The data showed that in rats, as oxygen levels increased from the pressure would cause an increase in gene expression.
Physiological Changes From Hyperbaric Oxygen
HBOT is currently recommended as a third-line treatment for post-vaccine symptoms, coined under the umbrella term of post COVID vaccine syndrome.
FLCCC doctors reason that both long COVID and post-vaccine symptoms are driven by a chronic exposure to spike protein, which promotes immune dysregulation and inflammation, this therefore makes conceptual sense that HBOT may work as a potential treatment.
Studies showed that HBOT could reduce inflammatory pathways and reduce the action of pro-inflammatory toll-like receptor pathways, both of which are often activated in acute COVID infections and spike protein-induced diseases.
Mitochondria are responsible for breaking down the sugar we ingested through our food, into energy, and uses oxygen as a key reactant of this biochemical process.
During inflammation experienced in long COVID and post-vaccine syndromes, the spike protein can stress the mitochondria in the cell, leading to reduced energy production and more production damaging radical species. Therefore the extra oxygen provided through the treatment gives ample material for use by the mitochondria to increase energy production for the body.
HBOT also induces the release of stem cells and tissue growth factors.
Many studies found the treatment to be beneficial in promoting tissue regeneration including the regeneration of muscle cells and generation of new blood vessels, this indicates that HBOT can help in the repair of tissue damaged from spike protein injuries.
Neurological symptoms are some of the major symptoms in long COVID and post-vaccine symptoms. There are also studies that showed that HBOT enhanced neurogenesis, though HBOT has not been approved by the Foods and Drug Administration for such treatment yet.
Harch has had successes in treating wounds in the brain including a near-reversal of brain damage in a drowned 2-year-old girl in 2017.
The girl had suffered from a deep brain injury and had “no speech, gait or responsiveness to commands with constant squirming and head shaking” he said.
But following 40 sessions, the girl had near-normal motor function, normal cognition, gait, and temperament, and improvement on nearly all neurological exam abnormalities. Her speech improved to a greater level than pre-drowning and she also discontinued all of her medications, according to the LSU Health New Orleans School of Medicine media release.
Studies have also found HBOT treatments increased blood flow and induced microstructural changes; this led to improved brain function including cognitive functions, gait, and sleep.
HBOT for Spike Protein-Induced Diseases
Studies on HBOT therapies have shown it to be beneficial against COVID and long COVID. There is much literature on HBOT that find positive outcomes in treating COVID infections.
All of the COVID patients presented low oxygen levels, rapid breathing, and inflammatory markers. After one to six sessions of HBOT, inflammatory markers fell and the rapid breathing ceased.
“Most importantly, HBOT potentially prevented the need for mechanical ventilation,” the authors wrote.
In a randomized controlled study from Argentina, HBOT was used to treat for low oxygen in COVID-19. The study was stopped after the interim analysis of 40 patients’ outcomes. The differences between the treatment and the non-treatment group were obvious.
Patients under treatment for HBOT improved their blood oxygen levels in three days, compared to the non-treatment group which took 9 days.
In particular, studies on long COVID showed that HBOT has significant improvements on fatigue, and brain fog by improving attention, memory, information processing, and mental health.
In an Israeli study published in July 2022 on 73 long COVID patients, half (37) were treated with HBOT and the other half (36) with placebo. The patients received treatments five times a week and the protocol included breathing pure oxygen by mask at 2 ATM for 90 minutes.
The authors noticed improvements in the HBOT treatment group in global cognitive function, attention, and executive function, with significant improvements in energy, sleep, mental health, and reduced pain.
Brain scans of these patients further showed improved blood flow in certain areas of the brain, suggestive of blood vessel formation.
The FLCCC recommends HBOT as a third line treatment as it is considered to be a treatment that “may be lifesaving for one patient and totally ineffective for another,” and is therefore less applicable for the general population.
Marik also acknowledged that the high cost of the therapy and differences in pathophysiology may not make the treatment suitable for everyone. They currently recommend HBOT only for severe neuropathologies in patients suffering from post-vaccine syndromes, particularly peripheral neural pain. Contraindications for this treatment include people with untreated pneumothorax.
About the Author: Marina Zhang is based in New York and covers health and science.
Base Spike Detox According to Dr Peter McCullough (in a X/Twitter post): Base Spike Detox is what I am currently using in my practice for those who have had COVID-19 multiple times, one or more of the COVID-19 vaccines, or both and believe persistent SARS-CoV-2 Spike protein could be causing problems in their body. I have arrived, based on the emerging scientific literature (1) and my clinical observation, that three OTC products are essential as a triple base combination: Nattokinase 2000 FU (100 mg) twice a day — take on an empty stomach Bromelain 500 mg once a day — take on an empty stomach Nano/Liposomal Curcumin 500 mg twice a day — take with food How long should I take this? Dr. McCullough recommends a minimum of 3 months , with many patients requiring 6–12 months or longer. Progress can be tracked via a spike protein antibody test (available through Labcorp in m...
Dr. McCullough explained (1) that the spike protein is an engineered, synthetic molecule roughly 1,200 amino acids long and resistant to degradation by the body’s normal proteases. He described how the protein was modified in laboratory settings (notably at the Wuhan Institute of Virology) to tightly bind to the ACE2 receptor, which is found throughout the body—in the lungs, heart, endothelium, kidneys, and brain. Because this receptor regulates angiotensin metabolism, older individuals with fewer ACE2 sites catabolize the spike less efficiently, leading to worse outcomes. Whether introduced by infection or by genetic‑code‑based vaccines, McCullough asserted, the persistent spike damages tissues directly and through chronic inflammation, micro‑clotting, and autoimmune cross‑reactivity. Spike Protein Protocol Personalizer Based on Dr. Peter McCullough's Base Spike Detox & FLCCC I-Recover Frameworks ⚠ Medical Disclaimer: This tool is...
An evidence-tiered review of the nattokinase, bromelain and curcumin regimen proposed by Dr. Peter McCullough: what it is, what the research does and does not show, how to use it safely, and how (not) to monitor it. By OneDayMD Editorial Team | Originally published March 2026 | Last updated October 18, 2026 | Sources reviewed through October 2026 | Next scheduled review: April 2027 Quick answer The McCullough Base Spike Detox is a clinician-proposed regimen of nattokinase (2,000 FU twice daily), bromelain (500 mg daily) and nano/liposomal curcumin (500 mg twice daily) intended to break down persistent SARS-CoV-2 spike protein. [1] Laboratory studies show nattokinase can degrade spike protein in cell and test-tube systems TIER 3 [2] [3] , and spike antigen does persist in a minority of people for months after infection TIER 2 [8] . Nattokinase and bromelain affect clotting, and highly bioavailable curcumin has been linked to rare liver injury, so check with a physician fi...
By OneDayMD Editorial Team · Published September 30, 2026 · Last updated: November 2026 Quick Answer: does anything work for Long COVID? No specific treatment has been proven to work for Long COVID in general. Randomized trials have found no benefit from extended Paxlovid (959 adults), metformin (396) or short-course hyperbaric oxygen (80). Promising but unconfirmed signals include the SIM01 synbiotic (463 people, Hong Kong), physical-activity coaching (50) and the Ultimate Spike Detox. For prevention during acute COVID, Paxlovid (144 people) and metformin show mixed or underpowered results. Care remains individualized and symptom-focused. Medical disclaimer. This article is educational and is not personal medical advice, diagnosis or treatment. Long COVID can overlap with cardiovascular, pulmonary, neurological, endocrine and sleep disorders. Do not start, stop or change pr...
Medically reviewed by: OneDayMD Editorial Team | Last updated: August 2026 Introduction The rapid development and deployment of COVID-19 vaccines have been monumental in combating the global pandemic, saving countless lives and enabling societies to regain a sense of normalcy. Central to the efficacy of many of these vaccines, particularly mRNA and viral vector-based ones, is the spike protein—a key component of the SARS-CoV-2 virus that facilitates its entry into human cells. By instructing the body to produce a version of this protein, vaccines train the immune system to recognize and neutralize the virus without causing illness. However, as vaccination campaigns expanded, so did public curiosity and concern about the spike protein's role, fueled by a mix of scientific complexity, misinformation, and distrust. For years, the public was told that COVID-19 mRNA vaccine components degraded rapidly—within days to weeks. Hulscher, McCullough, and colleagues' ...
Dr. Peter McCullough is an internist, cardiologist, epidemiologist, a full professor of medicine at Texas A&M College of Medicine in Dallas, USA. He also has a master's degree in public health and is known for being one of the top five most-published medical researchers in the United States and is the editor of two medical journals. McCullough Protocol 2022 Update: Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections: A Phase 2 Randomized Clinical Trial ( JAMA 2025 ) Everyone is familiar with nasal and oral swab testing for COVID-19. It should be obvious the virus is replicating in the nose, and with Omicron, the speed of replication has become much greater than the prior strains of the virus. Thus, there is a wonderful opportunity to reduce viral replication, in fa...
By OneDayMD Editorial Team · Originally published May 2022 · Last updated November 2026 · Sources reviewed through November 2026 Quick Answer Post-COVID-vaccination syndrome (PVS) describes persistent symptoms such as fatigue, exercise intolerance and brain fog that begin after vaccination. It is under active study, but there is no diagnostic test and no treatment proven in randomized trials . The FLCCC/IMA I-Recover protocol is a layered, off-label regimen (time-restricted eating, ivermectin, nattokinase, low-dose naltrexone, supplements) built from proposed mechanisms, clinical observation and patient anecdotes. Evidence-based first steps: see a clinician to exclude treatable causes (myocarditis, thyroid disease, anemia, POTS, sleep disorders), pace your activity, and consider joining a research study. The Independent Medical Alliance (IMA), previously known as the FLCCC, offers a detailed plan called the I-RECOVER protocol. It's a detailed guide for addressing post-...
Dose, blood pressure, carotid plaque, brain health and bleeding risk, graded by evidence tier. By Dr. Frank Yap, MD | Last Updated October 2026 Quick Answer Nattokinase is a clot-dissolving enzyme made by Bacillus subtilis during natto fermentation. Its best-supported human effect is a modest blood pressure drop (about 3 to 5 mmHg systolic) in randomized trials. Plaque regression has been reported only at 6,000 FU/day or higher, in studies that were unblinded or retrospective, while the largest placebo-controlled trial at 2,000 FU/day was null. No trial has measured heart attacks, strokes or deaths. It acts on clotting, so it should not be combined with blood thinners without a clinician, and it must never replace a prescribed anticoagulant. Contents What nattokinase is How it works Human evidence table (CEBM tiers) Blood pressure Plaque and the dose question Cholesterol Brain and stroke research Spike protein claims Natto the food vs. the enzyme Safety, inte...
By OneDayMD Editorial Team | Originally published May 2023 | Last updated October 2026 | Sources reviewed through October 2026 Quick Answer The FLCCC/IMA I-CARE Flu and RSV protocol is a home regimen of nasal and mouth antiseptics, supplements and off-label drugs. Most components are supported by laboratory or expert-opinion evidence, not influenza trials. The best-evidenced treatments for influenza are prescription antivirals started early: oseltamivir for hospitalized patients and baloxavir or oseltamivir for high-risk outpatients. Seek care promptly if you are high-risk or struggling to breathe. What changed in this update (October 2026) Fixed copy-paste wording that described the protocol as a COVID-19 guide. Replaced the claim that Tamiflu has “no antiviral properties.” Oseltamivir is a direct-acting neuraminidase inhibitor, and the 2025 paper is in JAMA Ne...
Immune Systems Advisor · Integrative Medicine White Paper · Open Access Authors: OneDayMD Editorial Team (synthesis and editorial adaptation) · Original protocols: Marik P, Kory P (IMA/FLCCC, 2022–2024); McCullough PA (Cureus, 2023) · Published: March 2023 · Last updated: August 2026 Evidence Tier Key: TIER 1 RCT / systematic review TIER 2 Observational / cohort TIER 3 In vitro / mechanistic TIER 4 Expert consensus / clinical observation ⚠ Medical Disclaimer — Please Read First. This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The protocols described involve supplements with significant anticoagulant activity. Always consult a licensed physician before starting, especially if you take blood thinners, are pregnant or breastfeeding, have a bleeding disorder, or are treating a child. For a virt...
Comments
Post a Comment